Closed · TI-15-007 · CFDA 93.243 · Discretionary

Targeted Capacity Expansion: Medication Assisted Treatment-Prescription Drug and Opioid Addiction (MAT-PDOA) grants

Federal grant opportunity posted by Substance Abuse and Mental Health Services Adminis, cataloged on Grants.gov.

up to $1M
Award range
Closed
Status
May 8, 2015
Close date
11
Expected awards

The verdict

Targeted Capacity Expansion: Medication Assisted Treatment-Prescription Drug and Opioid Addiction (MAT-PDOA) grants is a closed discretionary listing from Substance Abuse and Mental Health Services Adminis that offered Up to $1,000,000 across 11 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 232 other opportunities from Substance Abuse and Mental Health Services Adminis.

up to $1M
award range
Closed
application status
11
expected awards
93.243
CFDA program

Archived opportunity record

Targeted Capacity Expansion: Medication Assis… is closed (last close May 8, 2015). The parent program page for CFDA 93.243 is the reliable place to catch re-announcements. Substance Abuse and Mental Health Services Adminis still indexes 232 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed May 8, 2015

Posted Feb 26 Closes May 8

Est. Total Funding

$11,000,000

Expected Awards

11

Instrument

Grant

Description

The purpose of this program is to provide funding to states to enhance/expand their treatment service systems to increase capacity and provide accessible, effective, comprehensive, coordinated care, and evidence-based medication assisted treatment (MAT) and recovery support services to individuals with opioid use disorders seeking or receiving MAT. As a result of this program, SAMHSA seeks to: 1) increase the number of individuals receiving MAT services with pharmacotherapies approved by the FDA for the treatment of opioid use disorders; 2) increase the number of individuals receiving integrated care; and 3) decrease illicit drug use at 6-months follow-up. For the purpose of this RFA, integrated care is defined as the organized delivery and/or coordination of medical, behavioral or social and recovery support services provided to individual patients in order to produce better overall health outcomes for people that may have multiple healthcare needs. MAT is defined as the use of FDA-approved opioid agonist medications (e.g., methadone, buprenorphine products including buprenorphine/naloxone combination formulations and buprenorphine mono-product formulations) for the maintenance treatment of opioid use disorder and opioid antagonist medication (e.g., naltrexone products including extended-release and oral formulations) to prevent relapse to opioid use. MAT includes screening, assessment (which includes determination of severity of opioid use disorder, including presence of physical dependence and appropriateness for MAT) and case management. MAT is to be provided in combination with comprehensive substance use disorder treatment, including but not limited to: counseling, behavioral therapies and when needed pharmacotherapy for co-occurring alcohol use disorder. MAT is to be provided in a clinically driven, person-centered and individualized setting. Priority will be given to states (listed in Appendix V) that have not only demonstrated a high rate of primary treatment admissions for heroin and opioids per capita, but that have also demonstrated a dramatic increase in admissions in recent years. These states must include a statement confirming that their state has a rate of change for primary treatment admission for heroin and non-heroin opiates between the years 2007-2012 equal to or greater than 50 percent. In order to receive priority, this documentation must be included in Attachment 5.This program addresses SAMHSA’s Strategic Initiative on Prevention of Substance Abuse and Mental Illness.

Catch-all / unrestricted eligibility mark · TI-15-007

Grants.gov marks Targeted Capacity Expansion: Medication Assis… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Substance Abuse and Mental Health Services Adminis book (232 peers, 100% of 233).

Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Eileen Bermudez Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 1 Choke Cherry Road Room 7-1091 Rockville, Maryland 20857 (240) 276-1412

What to do next

Targeted Capacity Expansion: Medication Assis… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.243 may publish future NOFOs under the same assistance listing. Open program
  • Substance Abuse and Mental Health Services indexes 0 Grants.gov listings in this extract. Program profile
  • Substance Abuse and Mental Health Services Adminis lists 232 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants